Press Releases from prbd.netRss/rsscompary_13202.aspxprbd.net - Submit Press Release and get wide media coverageCopyright 2011 prbdEMR Releases a New Series of Reports on Key Antifungal Drug Markets https://www.prbd.net/news_31192.aspxEMR’s latest publications provide an exceptional tool to understand the current trends, therapeutic structure, competitive landscape and the outlook for key antifungal drug markets till 2016Wed, 28 Sep 2011 00:00:00 GMTNew Series of Reports By EMR provides an In-depth Insight into The Key Emerging Antibacterial Markethttps://www.prbd.net/news_31115.aspxEMR’s latest publications provide an exceptional tool to understand the current trends, therapeutic structure, competitive landscape and the outlook for key emerging Antibacterial drug markets till 2016Tue, 27 Sep 2011 00:00:00 GMTA Series of Reports By EMR provides an In-depth Insight into The Key Developed Antibacterial Markethttps://www.prbd.net/news_31074.aspxEMR’s latest publications provide an exceptional tool to understand the current trends, therapeutic structure, competitive landscape and the outlook for key developed Antibacterial drug markets till 2016Tue, 27 Sep 2011 00:00:00 GMTEMR Releases a New Series of Reports on Key Developed Erectile Dysfunction Drug Markets https://www.prbd.net/news_30841.aspxEMR’s latest publications provide an exceptional tool to understand the current trends, therapeutic structure, competitive landscape and the outlook for key developed erectile dysfunction markets till 2016.Fri, 23 Sep 2011 00:00:00 GMTEMR Releases a New Series of Reports on Key Hormonal Contraceptive Drug Markets https://www.prbd.net/news_30562.aspxEMR’s latest publications provide an exceptional tool to understand the current trends, therapeutic structure, competitive landscape and the outlook for key hormonal contraceptive drug markets till 2016.Wed, 21 Sep 2011 00:00:00 GMTEMR Launches New Reports on the Market Potential of HIV Drugs in Several Key Countrieshttps://www.prbd.net/news_28834.aspxA new series of reports from EMR provides an in-depth understanding of the market for HIV drugs.Tue, 30 Aug 2011 00:00:00 GMT